Barber M. Methicillin-resistant staphylococci. J Clin Pathol. 1961;14:385–93.
Lee AS, de Lencastre H, Garau J, Kluytmans J, Malhotra-Kumar S, Peschel A, et al. Methicillin-resistant Staphylococcus aureus. Nat Rev Dis Prim. 2018;4:18033.
Samuel P, Kumar YS, Suthakar BJ, Karawita J, Sunil Kumar D, Vedha V, et al. Methicillin-resistant Staphylococcus aureus colonization in intensive care and burn units: a narrative review. Cureus. 2023;15:e47139.
Sergelidis D, Angelidis AS. Methicillin-resistant Staphylococcus aureus: a controversial food-borne pathogen. Lett Appl Microbiol. 2017;64:409–18.
Nannini E, Murray BE, Arias CA. Resistance or decreased susceptibility to glycopeptides, daptomycin, and linezolid in methicillin-resistant Staphylococcus aureus. Curr Opin Pharm. 2010;10:516–21.
Cascioferro S, Carbone D, Parrino B, Pecoraro C, Giovannetti E, Cirrincione G, et al. Therapeutic strategies to counteract antibiotic resistance in MRSA biofilm-associated infections. ChemMedChem. 2021;16:65–80.
Fiorucci S, Distrutti E. Bile acid-activated receptors, intestinal microbiota, and the treatment of metabolic disorders. Trends Mol Med. 2015;21:702–14.
Ridlon JM, Kang DJ, Hylemon PB. Bile salt biotransformations by human intestinal bacteria. J Lipid Res. 2006;47:241–59.
Russell DW. The enzymes, regulation, and genetics of bile acid synthesis. Annu Rev Biochem. 2003;72:137–74.
Arifuzzaman M, Won TH, Li TT, Yano H, Digumarthi S, Heras AF, et al. Inulin fibre promotes microbiota-derived bile acids and type 2 inflammation. Nature. 2022;611:578–84.
Paik D, Yao L, Zhang Y, Bae S, D’Agostino GD, Zhang M, et al. Human gut bacteria produce Tau(Eta)17-modulating bile acid metabolites. Nature. 2022;603:907–12.
Funabashi M, Grove TL, Wang M, Varma Y, McFadden ME, Brown LC, et al. A metabolic pathway for bile acid dehydroxylation by the gut microbiome. Nature. 2020;582:566–70.
Campbell C, McKenney PT, Konstantinovsky D, Isaeva OI, Schizas M, Verter J, et al. Bacterial metabolism of bile acids promotes generation of peripheral regulatory T cells. Nature. 2020;581:475–9.
Hang S, Paik D, Yao L, Kim E, Trinath J, Lu J, et al. Bile acid metabolites control T(H)17 and T(reg) cell differentiation. Nature. 2019;576:143–8.
Song X, Sun X, Oh SF, Wu M, Zhang Y, Zheng W, et al. Microbial bile acid metabolites modulate gut RORgamma(+) regulatory T cell homeostasis. Nature. 2020;577:410–5.
Li W, Hang S, Fang Y, Bae S, Zhang Y, Zhang M, et al. A bacterial bile acid metabolite modulates T(reg) activity through the nuclear hormone receptor NR4A1. Cell Host Microbe. 2021;29:1366–77 e1369.
Sato Y, Atarashi K, Plichta DR, Arai Y, Sasajima S, Kearney SM, et al. Novel bile acid biosynthetic pathways are enriched in the microbiome of centenarians. Nature. 2021;599:458–64.
Barman S, Buzoglu Kurnaz L, Yang X, Nagarkatti M, Nagarkatti P, Decho AW, et al. Facially amphiphilic bile acid-functionalized antimicrobials: combating pathogenic bacteria, fungi, and their biofilms. ACS Infect Dis. 2023;9:1769–82.
Su J, Li H, Hu J, Wang D, Zhang F, Fu Z, et al. LcCCL28-25, derived from piscine chemokine, exhibits antimicrobial activity against gram-negative and gram-positive bacteria in vitro and in vivo. Microbiol Spectr. 2022;10:e0251521.
Wang C, Ji Y, Huo X, Li X, Lu W, Zhang Z, et al. Discovery of salifungin as a repurposed antibiotic against methicillin-resistant Staphylococcus aureus with limited resistance development. ACS Infect Dis. 2024;10:1576–89.
Zhu J, Wang Y, Wang W, Wu B, Lu Y, Du J, et al. Mptx2 defends against peritoneal infection by methicillin-resistant staphylococcus aureus. Int Immunopharmacol. 2022;108:108856.
Rajasekaran G, Kim EY, Shin SY. LL-37-derived membrane-active FK-13 analogs possessing cell selectivity, anti-biofilm activity and synergy with chloramphenicol and anti-inflammatory activity. Biochim Biophys Acta Biomembr. 2017;1859:722–33.
Rajasekaran G, Dinesh Kumar S, Nam J, Jeon D, Kim Y, Lee CW, et al. Antimicrobial and anti-inflammatory activities of chemokine CXCL14-derived antimicrobial peptide and its analogs. Biochim Biophys Acta Biomembr. 2019;1861:256–67.
Sandberg A, Hessler JH, Skov RL, Blom J, Frimodt-Moller N. Intracellular activity of antibiotics against Staphylococcus aureus in a mouse peritonitis model. Antimicrob Agents Chemother. 2009;53:1874–83.
Yan W, Chen S, Wang Y, You Y, Lu Y, Wang W, et al. Loss of Mptx2 alters bacteria composition and intestinal homeostasis potentially by impairing autophagy. Commun Biol. 2024;7:94.
Golden GJ, Toledo AG, Marki A, Sorrentino JT, Morris C, Riley RJ, et al. Endothelial heparan sulfate mediates hepatic neutrophil trafficking and injury during Staphylococcus aureus Sepsis. mBio. 2021;12:e0118121.
Shen W, Yang N, Teng D, Hao Y, Ma X, Mao R, et al. Design and high expression of non-glycosylated lysostaphins in pichia pastoris and their pharmacodynamic study. Front Microbiol. 2021;12:637662.
Miyamoto Y, Kikuta J, Matsui T, Hasegawa T, Fujii K, Okuzaki D, et al. Periportal macrophages protect against commensal-driven liver inflammation. Nature. 2024;629:901–9.
Tacconelli E, Carrara E, Savoldi A, Harbarth S, Mendelson M, Monnet DL, et al. Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis. Lancet Infect Dis. 2018;18:318–27.
Vestergaard M, Frees D, Ingmer H. Antibiotic resistance and the MRSA problem. Microbiol Spectr. 2019;7:GPP3-0057-2018.
Falany CN, Johnson MR, Barnes S, Diasio RB. Glycine and taurine conjugation of bile acids by a single enzyme. Molecular cloning and expression of human liver bile acid CoA:amino acid N-acyltransferase. J Biol Chem. 1994;269:19375–9.
Foley MH, Walker ME, Stewart AK, O’Flaherty S, Gentry EC, Patel S, et al. Bile salt hydrolases shape the bile acid landscape and restrict Clostridioides difficile growth in the murine gut. Nat Microbiol. 2023;8:611–28.
Thanissery R, Winston JA, Theriot CM. Inhibition of spore germination, growth, and toxin activity of clinically relevant C. difficile strains by gut microbiota derived secondary bile acids. Anaerobe. 2017;45:86–100.
Buffie CG, Bucci V, Stein RR, McKenney PT, Ling L, Gobourne A, et al. Precision microbiome reconstitution restores bile acid mediated resistance to Clostridium difficile. Nature. 2015;517:205–8.
Dobson TE, Maxwell AR, Ramsubhag A. Antimicrobial cholic acid derivatives from the Pitch Lake bacterium Bacillus amyloliquefaciens UWI-W23. Steroids. 2018;135:50–53.
Sannasiddappa TH, Lund PA, Clarke SR. In vitro antibacterial activity of unconjugated and conjugated bile salts on Staphylococcus aureus. Front Microbiol. 2017;8:1581.
Lin C, Wang Y, Le M, Chen KF, Jia YG. Recent progress in bile acid-based antimicrobials. Bioconjug Chem. 2021;32:395–410.
Del Pozo JL. Biofilm-related disease. Expert Rev Anti Infect Ther. 2018;16:51–65.
Schilcher K, Horswill AR. Staphylococcal biofilm development: structure, regulation, and treatment strategies. Microbiol Mol Biol Rev. 2020;84:e00026–19.
Roy R, Tiwari M, Donelli G, Tiwari V. Strategies for combating bacterial biofilms: a focus on anti-biofilm agents and their mechanisms of action. Virulence. 2018;9:522–54.
Torres NS, Abercrombie JJ, Srinivasan A, Lopez-Ribot JL, Ramasubramanian AK, Leung KP. Screening a commercial library of pharmacologically active small molecules against Staphylococcus aureus biofilms. Antimicrob Agents Chemother. 2016;60:5663–72.
Hurdle JG, O’Neill AJ, Chopra I, Lee RE. Targeting bacterial membrane function: an underexploited mechanism for treating persistent infections. Nat Rev Microbiol. 2011;9:62–75.
Epand RF, Pollard JE, Wright JO, Savage PB, Epand RM. Depolarization, bacterial membrane composition, and the antimicrobial action of ceragenins. Antimicrob Agents Chemother. 2010;54:3708–13.
Chen WH, Shao XB, Moellering R, Wennersten C, Regen SL. A bioconjugate approach toward squalamine mimics: Insight into the mechanism of biological action. Bioconjug Chem. 2006;17:1582–91.
Yang L, Zhan C, Huang X, Hong L, Fang L, Wang W, et al. Durable antibacterial cotton fabrics based on natural borneol-derived anti-MRSA agents. Adv Health Mater. 2020;9:e2000186.
